Literature DB >> 15664806

Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonists.

Michel Belley1, Michel Gallant, Bruno Roy, Karine Houde, Nicolas Lachance, Marc Labelle, Laird A Trimble, Nathalie Chauret, Chun Li, Nicole Sawyer, Nathalie Tremblay, Sonia Lamontagne, Marie-Claude Carrière, Danielle Denis, Gillian M Greig, Deborah Slipetz, Kathleen M Metters, Robert Gordon, Chi Chung Chan, Robert J Zamboni.   

Abstract

A series of novel ortho-substituted cinnamic acids have been synthesized, and their binding activity and selectivity on the four prostaglandin E(2) receptors evaluated. Many of them are very potent and selective EP(3) antagonists (K(i) 3-10 nM), while compound 9 is a very good and selective EP(2) agonist (K(i) 8 nM). The biological profile of the EP(2) agonist 9 in vivo and the metabolic profile of selected EP(3) antagonists are also reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664806     DOI: 10.1016/j.bmcl.2004.11.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.

Authors:  R L Jones; D F Woodward; J W Wang; R L Clark
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Fluorescent Human EP3 Receptor Antagonists.

Authors:  Miriam Tomasch; J Stephan Schwed; Karina Kuczka; Sascha Meyer Dos Santos; Sebastian Harder; Rolf M Nüsing; Alexander Paulke; Holger Stark
Journal:  ACS Med Chem Lett       Date:  2012-08-08       Impact factor: 4.345

Review 3.  Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

Authors:  Jianxiong Jiang; Ray Dingledine
Journal:  Trends Pharmacol Sci       Date:  2013-06-21       Impact factor: 14.819

4.  Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.

Authors:  R L Jones; D F Woodward
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 5.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

Review 6.  Mapping PTGERs to the Ovulatory Follicle: Regional Responses to the Ovulatory PGE2 Signal.

Authors:  Soon Ok Kim; Diane M Duffy
Journal:  Biol Reprod       Date:  2016-06-15       Impact factor: 4.285

7.  Synthesis of Bio-Inspired 1,3-Diarylpropene Derivatives via Heck Cross-Coupling and Cytotoxic Evaluation on Breast Cancer Cells.

Authors:  Aik Sian Tan; Jaymeer Singh; Nurul Syafiqah Rezali; Musthahimah Muhamad; Nik Nur Syazni Nik Mohamed Kamal; Yvan Six; Mohamad Nurul Azmi
Journal:  Molecules       Date:  2022-08-23       Impact factor: 4.927

8.  Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.

Authors:  Michelle E Kimple; Mark P Keller; Mary R Rabaglia; Renee L Pasker; Joshua C Neuman; Nathan A Truchan; Harpreet K Brar; Alan D Attie
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

Review 9.  EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

Authors:  Madison N Sluter; Ruida Hou; Lexiao Li; Nelufar Yasmen; Ying Yu; Jiawang Liu; Jianxiong Jiang
Journal:  J Med Chem       Date:  2021-08-05       Impact factor: 8.039

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.